…he case of a man in his 60s receiving the ICI pembrolizumab for lung adenocarcinoma, who presented with acute renal failure requiring renal replace…
lung adenocarcinoma
This disease is selected. Its supporting articles are shown below.
Articles mentioning lung adenocarcinoma
32 articles · page 2 of 3…Background and Importance Non-squamous non-small-cell lung cancer (NSCLC) remains one of the leading causes of cancer-related mor…
…performed a prospective study (n=113) in patients with advanced NSCLC treated with single agent ICIs and correlated clinopathological…
…sociated with poor prognosis and immune suppression in TNBC and LUAD. Notably, targeting AKR1B1 improves responses to ICIs in both b…
…ted for 2 months. 3 years before, she had undergone surgery for lung adenocarcinoma, followed by chemotherapy. On examination, there was a postural…
…read to the gastrointestinal tract are lung, breast, kidney and melanoma. Symptoms can vary, but patients are usually asymptomatic, pres…
…dagrasib, evaluated in KRYSTAL-1, showed comparable efficacy in NSCLC (ORR ~43%, PFS 6.5 months, OS 12.6 months) and similarly receiv…
…udin18.2 might be a potential biomarker for targeted therapy on lung mucinous adenocarcinoma, cholangiocarcinoma, colorectal mucinous adenocarcinoma and gas…
…nd 2024. Eligible patients had a diagnosis of cancer (including melanoma, squamous cell carcinoma, basal cell carcinoma, Merkel cell car…
…ls and tumor types including lung adenocarcinoma, melanoma, and Merkel cell carcinoma which had been imaged and processed through our AstroPath pipel…
…Background LKB1 mutant lung adenocarcinoma is a frequently occurring and aggressive genetic subtype of lun…
…PDGF and MIF. Experimental results indicate that STK24 promotes LUAD cell proliferation and inhibits apoptosis, highlighting its cri…